Genotypic differences of MCAD deficiency in the Asian population

Novel genotype and clinical symptoms preceding newborn screening notification

Regina Ensenauer, Jennifer L. Winters, Patricia A. Parton, David F. Kronn, Jong Won Kim, Dietrich Matern, Piero Rinaldo, Si Houn Hahn

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose: In contrast to its high prevalence in Caucasians, medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is reported to be an extremely rare metabolic disorder in the Asian population. The common MCAD gene (ACADM) mutation 985A>G (p.K329E), accounting for the majority of cases in Caucasians, has not been detected in this ethnic group, and the spectrum of ACADM mutations has remained unknown. Method: Biochemical genetic testing including plasma acylcarnitine and urine acylglycine analyses, as well as sequencing of ACADM was performed in a Korean family with a newborn who had an elevated octanoyl (C8) carnitine concentration by newborn screening (NBS). Genotyping of 50 Korean newborns with normal NBS results was performed. Result: We report the identification of the first Korean patient with MCAD deficiency, caused by a novel missense mutation in ACADM, 843A>T (R281S), and a 4-bp deletion, c.449_452delCTGA. The patient became symptomatic before notification of the abnormal NBS result. Both the father and a brother who were identified as carriers for the 4-bp deletion had mildly elevated plasma C8 and C10:1 carnitine concentrations, whereas the acylcarnitine profile was normal in the mother who carries the missense mutation. Conclusion: The 4-bp deletion may represent a common Asian ACADM mutation, considering that it recently has also been found in two of the three Japanese patients in whom genotyping was performed. Greater availability of MCAD mutation analysis is likely to unravel the molecular basis of MCAD deficiency in the Asian population that might differ from Caucasians.

Original languageEnglish (US)
Pages (from-to)339-343
Number of pages5
JournalGenetics in Medicine
Volume7
Issue number5
DOIs
StatePublished - May 2005

Fingerprint

Genotype
Newborn Infant
Acyl-CoA Dehydrogenase
Mutation
Carnitine
Population
Missense Mutation
Genetic Testing
Ethnic Groups
Fathers
Siblings
Molecular Biology
Mothers
Medium chain acyl CoA dehydrogenase deficiency
Urine
Genes
acylcarnitine

Keywords

  • Asian
  • Genotype
  • Korean
  • MCAD deficiency
  • Newborn screening

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Genotypic differences of MCAD deficiency in the Asian population : Novel genotype and clinical symptoms preceding newborn screening notification. / Ensenauer, Regina; Winters, Jennifer L.; Parton, Patricia A.; Kronn, David F.; Kim, Jong Won; Matern, Dietrich; Rinaldo, Piero; Hahn, Si Houn.

In: Genetics in Medicine, Vol. 7, No. 5, 05.2005, p. 339-343.

Research output: Contribution to journalArticle

Ensenauer, Regina ; Winters, Jennifer L. ; Parton, Patricia A. ; Kronn, David F. ; Kim, Jong Won ; Matern, Dietrich ; Rinaldo, Piero ; Hahn, Si Houn. / Genotypic differences of MCAD deficiency in the Asian population : Novel genotype and clinical symptoms preceding newborn screening notification. In: Genetics in Medicine. 2005 ; Vol. 7, No. 5. pp. 339-343.
@article{e8707ccb9af743839a99efc8a7538301,
title = "Genotypic differences of MCAD deficiency in the Asian population: Novel genotype and clinical symptoms preceding newborn screening notification",
abstract = "Purpose: In contrast to its high prevalence in Caucasians, medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is reported to be an extremely rare metabolic disorder in the Asian population. The common MCAD gene (ACADM) mutation 985A>G (p.K329E), accounting for the majority of cases in Caucasians, has not been detected in this ethnic group, and the spectrum of ACADM mutations has remained unknown. Method: Biochemical genetic testing including plasma acylcarnitine and urine acylglycine analyses, as well as sequencing of ACADM was performed in a Korean family with a newborn who had an elevated octanoyl (C8) carnitine concentration by newborn screening (NBS). Genotyping of 50 Korean newborns with normal NBS results was performed. Result: We report the identification of the first Korean patient with MCAD deficiency, caused by a novel missense mutation in ACADM, 843A>T (R281S), and a 4-bp deletion, c.449_452delCTGA. The patient became symptomatic before notification of the abnormal NBS result. Both the father and a brother who were identified as carriers for the 4-bp deletion had mildly elevated plasma C8 and C10:1 carnitine concentrations, whereas the acylcarnitine profile was normal in the mother who carries the missense mutation. Conclusion: The 4-bp deletion may represent a common Asian ACADM mutation, considering that it recently has also been found in two of the three Japanese patients in whom genotyping was performed. Greater availability of MCAD mutation analysis is likely to unravel the molecular basis of MCAD deficiency in the Asian population that might differ from Caucasians.",
keywords = "Asian, Genotype, Korean, MCAD deficiency, Newborn screening",
author = "Regina Ensenauer and Winters, {Jennifer L.} and Parton, {Patricia A.} and Kronn, {David F.} and Kim, {Jong Won} and Dietrich Matern and Piero Rinaldo and Hahn, {Si Houn}",
year = "2005",
month = "5",
doi = "10.1097/01.GIM.0000164548.54482.9D",
language = "English (US)",
volume = "7",
pages = "339--343",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Genotypic differences of MCAD deficiency in the Asian population

T2 - Novel genotype and clinical symptoms preceding newborn screening notification

AU - Ensenauer, Regina

AU - Winters, Jennifer L.

AU - Parton, Patricia A.

AU - Kronn, David F.

AU - Kim, Jong Won

AU - Matern, Dietrich

AU - Rinaldo, Piero

AU - Hahn, Si Houn

PY - 2005/5

Y1 - 2005/5

N2 - Purpose: In contrast to its high prevalence in Caucasians, medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is reported to be an extremely rare metabolic disorder in the Asian population. The common MCAD gene (ACADM) mutation 985A>G (p.K329E), accounting for the majority of cases in Caucasians, has not been detected in this ethnic group, and the spectrum of ACADM mutations has remained unknown. Method: Biochemical genetic testing including plasma acylcarnitine and urine acylglycine analyses, as well as sequencing of ACADM was performed in a Korean family with a newborn who had an elevated octanoyl (C8) carnitine concentration by newborn screening (NBS). Genotyping of 50 Korean newborns with normal NBS results was performed. Result: We report the identification of the first Korean patient with MCAD deficiency, caused by a novel missense mutation in ACADM, 843A>T (R281S), and a 4-bp deletion, c.449_452delCTGA. The patient became symptomatic before notification of the abnormal NBS result. Both the father and a brother who were identified as carriers for the 4-bp deletion had mildly elevated plasma C8 and C10:1 carnitine concentrations, whereas the acylcarnitine profile was normal in the mother who carries the missense mutation. Conclusion: The 4-bp deletion may represent a common Asian ACADM mutation, considering that it recently has also been found in two of the three Japanese patients in whom genotyping was performed. Greater availability of MCAD mutation analysis is likely to unravel the molecular basis of MCAD deficiency in the Asian population that might differ from Caucasians.

AB - Purpose: In contrast to its high prevalence in Caucasians, medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is reported to be an extremely rare metabolic disorder in the Asian population. The common MCAD gene (ACADM) mutation 985A>G (p.K329E), accounting for the majority of cases in Caucasians, has not been detected in this ethnic group, and the spectrum of ACADM mutations has remained unknown. Method: Biochemical genetic testing including plasma acylcarnitine and urine acylglycine analyses, as well as sequencing of ACADM was performed in a Korean family with a newborn who had an elevated octanoyl (C8) carnitine concentration by newborn screening (NBS). Genotyping of 50 Korean newborns with normal NBS results was performed. Result: We report the identification of the first Korean patient with MCAD deficiency, caused by a novel missense mutation in ACADM, 843A>T (R281S), and a 4-bp deletion, c.449_452delCTGA. The patient became symptomatic before notification of the abnormal NBS result. Both the father and a brother who were identified as carriers for the 4-bp deletion had mildly elevated plasma C8 and C10:1 carnitine concentrations, whereas the acylcarnitine profile was normal in the mother who carries the missense mutation. Conclusion: The 4-bp deletion may represent a common Asian ACADM mutation, considering that it recently has also been found in two of the three Japanese patients in whom genotyping was performed. Greater availability of MCAD mutation analysis is likely to unravel the molecular basis of MCAD deficiency in the Asian population that might differ from Caucasians.

KW - Asian

KW - Genotype

KW - Korean

KW - MCAD deficiency

KW - Newborn screening

UR - http://www.scopus.com/inward/record.url?scp=20444505209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444505209&partnerID=8YFLogxK

U2 - 10.1097/01.GIM.0000164548.54482.9D

DO - 10.1097/01.GIM.0000164548.54482.9D

M3 - Article

VL - 7

SP - 339

EP - 343

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 5

ER -